Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20355)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | GR50 | GRmax | GR_AOC | GEC50 | GRinf | GR Hill Coefficient | GR r2 | pval_GR |
---|---|---|---|---|---|---|---|---|---|
MDA-MB-468 | Senexin B | 1.994645521 | 0.1170 | 0.2810 | 51.8931 | -1.0000 | 0.3371 | 0.8162 | 6.38e-10 |
CAL-51 | Ulixertinib | 20.08181132 | 0.7439 | 0.0569 | 48.1868 | -0.9997 | 1.2549 | 0.4674 | 0.000380369 |
SUM149PT | Ulixertinib | 2.037761408 | 0.1734 | 0.2350 | 4.8956 | -0.2916 | 0.5241 | 0.9161 | 3.52e-14 |
MDA-MB-453 | GSK2334470 | 2.045052119 | 0.1203 | 0.2628 | 36.8285 | -1.0000 | 0.3800 | 0.7865 | 4.15e-09 |
MCF7 | Rucaparib | 20.52571528 | 0.5466 | 0.0691 | 95.2231 | -1.0000 | 0.7159 | 0.5083 | 0.000140012 |
HCC38 | AZD6738 | 2.069548926 | -0.2338 | 0.2316 | 6.8694 | -1.0000 | 0.9157 | 0.9405 | 4.44e-16 |
SUM159PT | MK 1775 | 2.079002463 | -0.1602 | 0.2571 | 9.8880 | -1.0000 | 0.7045 | 0.8868 | 1.5e-12 |
HCC1937 | GSK2334470 | 21.07472865 | 0.5809 | 0.1504 | 509.5331 | -1.0000 | 0.3449 | 0.4204 | 0.00109344 |
MCF 10A | Ribociclib | 21.11238563 | 0.4876 | 0.1616 | 1000.0000 | -1.0000 | 0.2848 | 0.8863 | 1.58e-12 |
HCC1954 | Senexin B | 211.891286993 | 0.4085 | 0.3284 | 0.0138 | 0.4972 | 0.5378 | 0.5891 | 1.48480209144e-05 |
HCC1143 | Rucaparib | 212371.6019 | 0.7856 | 0.0507 | 630.9562 | 0.3840 | 0.2511 | 0.2497 | 0.027576264 |
CAL-120 | BMS-265246 | 2.125230074 | 0.3446 | 0.3401 | 1000.0000 | -0.9133 | 0.1688 | 0.8479 | 6e-11 |
HCC1428 | AZD2014 | 2.19e-05 | -0.5555 | 1.2048 | 0.0005 | -0.5838 | 0.2503 | 0.4940 | 0.000200146 |
Hs 578T | SHP099 | 222.1051901 | 0.5953 | 0.1451 | 1000.0000 | -0.2087 | 0.2319 | 0.7318 | 7.17e-08 |
BT-20 | Senexin B | 2.23064370113 | 0.0956 | 0.2772 | 71.2131 | -1.0000 | 0.3172 | 0.7918 | 3.02648173189e-09 |
SUM1315MO2 | SHP099 | 22.32790504 | 0.4783 | 0.1197 | 419.3194 | -1.0000 | 0.3746 | 0.3197 | 0.008107411 |
CAL-51 | GSK2334470 | 22.73047392 | 0.8334 | 0.0336 | 53.5738 | -0.9998 | 1.2813 | 0.2592 | 0.023515658 |
MDA-MB-134-VI | LY3023414 | 2.28e-05 | -0.9131 | 1.4118 | 0.0019 | -1.0000 | 0.2471 | 0.8907 | 9.62e-13 |
SUM149PT | Ribociclib | 229.6984296 | 0.5649 | 0.1855 | 1.4808 | 0.4031 | 0.3252 | 0.8653 | 1.31e-11 |
MDA-MB-468 | AZD5363 | 23.1790046 | 0.5103 | 0.1319 | 558.0456 | -1.0000 | 0.3453 | 0.7227 | 1.09e-07 |
SUM1315MO2 | Ribociclib | 2.417104164 | 0.4065 | 0.3624 | 0.0997 | 0.2788 | 0.2557 | 0.5827 | 1.8e-05 |
Hs 578T | Senexin B | 2420179.078 | 0.7716 | 0.1355 | 1000.0000 | 0.3393 | 0.1457 | 0.6302 | 3.97e-06 |
HCC1500 | LY3023414 | 2.44e-06 | -0.9965 | 1.9835 | 0.0000 | -0.9955 | 0.7773 | 0.6628 | 1.25e-06 |
HCC1419 | MK 1775 | 2.452749667 | -0.0791 | 0.2879 | 12.3795 | -1.0000 | 0.6786 | 0.7916 | 3.06e-09 |
CAMA-1 | Ulixertinib | 2.566161953 | 0.1288 | 0.2586 | 42.4009 | -1.0000 | 0.3917 | 0.5616 | 3.34e-05 |